Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
10.04. | Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts | ||
09.04. | Trump pauses most reciprocal tariffs, hikes China's further | ||
09.04. | Ferring gene therapy sales grow; ASH calls for restoration of cut CDC division | ||
09.04. | Trump says 'major' tariffs coming on pharmaceuticals | ||
08.04. | US risks losing biotech edge to China, report warns | ||
08.04. | Rallybio discontinues lead drug for rare maternal disorder | ||
08.04. | Tango Therapeutics cuts nearly one-fifth of staff | ||
08.04. | Judge permanently blocks Trump admin plan to cap NIH funding, setting up appeals battle | ||
07.04. | RFK Jr. won't appear before Senate panel this week | ||
07.04. | GSK targets neurodegenerative diseases with latest licensing deal | ||
07.04. | Obesity drug data helps Rhythm defy market slide | ||
07.04. | Trump rejects Biden-era plan to let Medicare cover obesity drugs | ||
04.04. | Tariffs send healthcare industry into 'unchartered waters' | ||
04.04. | Trial monitors recommend Elevidys studies continue; Novartis kidney drug approved | ||
04.04. | M&A recap: Big pharma starts the year mostly avoiding billion-dollar deals | ||
03.04. | Roche halts testing of Sarepta Duchenne gene therapy in Europe | ||
03.04. | FDA misses approval deadline for Novavax's COVID-19 vaccine | ||
03.04. | Biotech 'megarounds' hold steady as startups, VCs wait on IPOs | ||
03.04. | Trump installs sweeping new tariffs, but pharma appears to dodge blow | ||
02.04. | Leqembi's EU review drags on; Sanofi gets a new development head | ||
02.04. | 'A cruel April Fool's joke': HHS layoffs characterized by confusion, errors | ||
02.04. | FDA device office hit in HHS layoffs | ||
02.04. | Newly launched genetic medicine CDMO acquires Landmark Bio | ||
01.04. | HHS begins layoffs in chaotic fashion | ||
01.04. | Judge overturns FDA's lab developed test regulation, siding with industry |